Study: Omicron evades some but not all monoclonal antibodies

Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern - eBioMedicine

Advances in the Omicron variant development - Vitiello - 2022 - Journal of Internal Medicine - Wiley Online Library

Can Covid vaccine provide immune protection against Omicron? See what latest study says

How Omicron escapes from antibodies, MIT News

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization

COVID-19: Omicron may not evade all monoclonal antibodies, says study - BusinessToday

Omicron Appears to Evade Vaccines Better Than Other Variants

The omicron variant is surging. Here's what we've learned so far

Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic - ScienceDirect

A COVID treatment wanes: New variants outsmart most monoclonal antibodies : Shots - Health News : NPR